Searchable abstracts of presentations at key conferences in endocrinology

ea0065p395 | Thyroid | SFEBES2019

Thyroid dysfunction is common in hospitalised patients with pre-existing levothyroxine treated hypothyroidism

Torlinska Barbara , Coleman Jamie J , Boelaert Kristien

Background: Levothyroxine replacement for hypothyroidism is safe and effective but may be associated with reduced quality of life and serious adverse effects if administered inappropriately. We set out to investigate if thyroid hormone profiles in hospitalised patients on levothyroxine are similar to those in inpatients without pre-existing thyroid dysfunction.Methods: We conducted a cross-sectional study in patients admitted for non-endocrine reasons to...

ea0062p43 | Poster Presentations | EU2019

Thyroid storm - from clinic to intensive care

Chortis Vasileios , Hazlehurst Jonathan , Boelaert Kristien

Case history: A 46-year-old female patient presented to A&E with a three day history of diarrhoea and vomiting, after three months of progressive weight loss. Her past medical history included chronic autoimmune thrombocytopaenia and Graves’ disease, which had been diagnosed four years earlier and treated with a brief course of propylthyuracil (PTU). She was clinically in extremis, with signs of severe cardiovascular and respiratory compromise and reduced res...

ea0044p253 | Thyroid | SFEBES2016

Prognostic factors of unsuccessful medical treatment of hyperthyroidism; longitudinal analysis of outcomes in the cohort of 538 patients

Torlinska Barbara , Johnson Oliver , Boelaert Kristien

A prolonged course of antithyroid drugs (ATD) is commonly used as first line treatment in patients with hyperthyroidism, although long term cure rates are poor – 40–50%. We performed a longitudinal analysis of outcomes in patients treated with a complete course of ATD and identified factors predicting remission.583 consecutive patients with newly diagnosed hyperthyroidism presenting between 2005 and 2014 and treated with ATD for a minimum of 6 ...

ea0034p413 | Thyroid | SFEBES2014

Myxoedema coma in a patient with bipolar disorder

Jahagirdar Vidhya , May Christine , Boelaert Kristien

A 63-year-old woman with a history of bipolar disorder and hypothyroidism under section 3 of the Mental Health Act in a psychiatric centre was admitted with severe hypothermia, bradycardia, hypotension and decreased GCS. She was on procyclidine and haloperidol for bipolar disorder and on intravenous antibiotics for 2 days for recurrent cellulitis in her leg. She was on levothyroxine 50 μg daily but was non compliant with her medications.Thyroid func...

ea0025p348 | Thyroid | SFEBES2011

Weight gain following treatment of hyperthyroidism depends on gender and disease severity but not on the treatment administered

Torlinska Barbara , Franklyn Jayne , Boelaert Kristien

Obesity is a global heath concern and the proportion of overweight and obese people in the UK is rapidly increasing. Patients undergoing treatment for hyperthyroidism frequently express concerns regarding excessive weight gain especially when offered treatment with 131I. We followed 1159 patients with overt hyperthyroidism to determine the extent of weight changes and to identify risk factors for weight gain following treatment. Overall, BMI remained unchanged in 13...

ea0021p408 | Thyroid | SFEBES2009

Characteristics of patients requiring more than one dose of radioactive iodine to induce cure of hyperthyroidism

Torlinska Barbara , Franklyn Jayne , Boelaert Kristien

The administration of radioactive iodine (131I) is widely used in the treatment of patients with hyperthyroidism. We have previously reported better cure rates in patients receiving a single dose of 600 MBq 131I compared with those treated with lower doses. We set out to evaluate if baseline patient characteristics predict which patients require multiple doses of radioiodine to induce cure. We compared 42 subjects requiring ≥3 doses with 290 patient...

ea0086p109 | Neuroendocrinology and Pituitary | SFEBES2022

A TSH-secreting pituitary adenoma cured from SSA monotherapy alone: Disease free more than three years after stopping treatment

Bhavra Kirandeep , Hamblin Ross , Ayuk John , Boelaert Kristien , Karavitaki Niki

Introduction: TSH-secreting pituitary adenomas (TSHomas) are rare pituitary tumours treated primarily with surgery; in cases of surgical failure, somatostatin analogue (SSA) or radiotherapy are further options. SSAs are rarely used as monotherapy; if responsive and in the absence of radiotherapy, the requirement of life-long medical treatment, is unknown. Herein, we present a patient with a TSHoma who remains in remission three years after SSA withdrawal.<p class="abstext"...

ea0065p10 | Adrenal and Cardiovascular | SFEBES2019

Thyroid hormone receptors in the mouse kidney in health and chronic kidney disease

Tasinato Elena , Boelaert Kristien , Long David , Vasilopoulou Elisavet

Introduction: Chronic kidney disease (CKD) is a devastating condition characterised by progressive loss of renal function that leads to end-stage renal disease. In patients with CKD there is increased prevalence of subclinical hypothyroidism. The importance of thyroid hormone (TH) action on kidney development, growth and physiology has been established, however the role of TH on kidney disease progression is not well understood.Aim: To assess the express...

ea0048cb6 | Additional Cases | SFEEU2017

Complex thyroid cancer with likely underlying TSHoma – a medical challenge

Kempegowda Punith , Ayuk John , Toogood Andy , O'Reilly Michael , Boelaert Kristien

A 22-year-old Caucasian female was referred to thyroid specialist clinic due to difficulties fully suppressing her thyroid stimulating hormone (TSH) despite high dose combination therapy of triiodothyronine (T3) and thyroxine (T4) treatment. She had a well-differentiated thyroid -carcinoma of left thyroid lobe treated with left lobectomy. Several other small primary thyroid carcinoma lesions were detected on further examination of the histology which lead to completion thyroid...

ea0038p440 | Thyroid | SFEBES2015

Increased rehospitalisation rate and cardiovascular morbidity in inpatients with hyperthyroidism – a matched case–control study

Torlinska Barbara , Hodson James , Franklyn Jayne , Coleman Jamie , Boelaert Kristien

Background: Hyperthyroidism often runs an indolent course and may be undiagnosed for prolonged periods. Most patients are treated in the outpatient setting and the effects of hyperthyroidism on hospitalised patients are poorly studied. We set out to determine the prevalence of hyperthyroidism in a large cohort of inpatients and evaluated their comorbidities, reasons for hospitalisation and rehospitalisation rates.Methods: A case-control study was conduct...